Log in to your Inderes Free account to see all free content on this page.
Gabather
0.04 SEK
-32.19 %
Less than 1K followers
GABA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Gabather
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| growth-% | |||||||
| EBITDA | -14.2 | -14.7 | -17.0 | -8.6 | -9.5 | -7.8 | -4.5 |
| EBIT | -14.3 | -14.8 | -17.0 | -8.6 | -9.5 | -7.8 | -4.5 |
| Profit before taxes | -14.3 | -14.7 | -17.0 | -8.6 | -9.4 | -7.8 | -4.7 |
| Net income | -14.3 | -14.7 | -17.0 | -8.6 | -9.4 | -7.8 | -4.7 |
| EPS | -0.39 | -0.28 | -0.33 | -0.16 | -0.17 | -0.10 | -0.02 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | |||||||
| EBIT-% | |||||||
| ROE | -32.8 % | -51.1 % | -155.0 % | -248.5 % | -1,926.5 % | 185.4 % | -702.7 % |
| ROI | -31.0 % | -45.8 % | -110.4 % | -126.7 % | -128.3 % | -423.5 % | -86.9 % |
Login required
This content is only available for logged in users